COMMUNIQUÉS West-GlobeNewswire

Scilex Holding Announces Strong ZTlido Sales Growth After Successful Post-Merger Integration
05/06/2019
ZTlido ® gross sales grew from approximately $1 million in March to $2.4 million in April and $3.3 million in May SP-102 pivotal phase 3 trial remains on track for completion in H1 2020 ZTlido ® 5.4% (3 X strength) [...]
AnaptysBio Presents Updated Data from Etokimab Phase 2a Proof-of-Concept Clinical Trial in Severe Eosinophilic Asthma
05/06/2019
Single dose of etokimab resulted in rapid and sustained lung function improvement and ACQ-5 score reduction through at least Day 64 Etokimab was well tolerated and no serious adverse events were reported Data supports [...]
BeiGene to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
05/06/2019
CAMBRIDGE, Mass. and BEIJING, China, June 05, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Teleflex to Present at the Raymond James Life Sciences and MedTech Conference
05/06/2019
WAYNE, Pa., June 05, 2019 (GLOBE NEWSWIRE) -- Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James Life Sciences and MedTech [...]
TRU NIAGEN® Awarded ‘Ingredient of the Year: Healthy Aging’ by NutraIngredients-USA
05/06/2019
ChromaDex receives industry award for its safety record and the robust research behind its NAD-boosting ingredient, Tru Niagen (nicotinamide riboside) LOS ANGELES, June 05, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. ( [...]
The Ensign Group Acquires Texas Post-Acute Care Campus
05/06/2019
MISSION VIEJO, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]
Neovacs to present the pre-clinical results of its IFNalpha Kinoid to treat type 1 diabetes - American Diabetes Association's 79th scientific sessions
05/06/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT THE PRE-CLINICAL RESULTS OF ITS IFNα KINOID TO TREAT TYPE 1 DIABETES AT T HE AMERICAN DIABETES ASSOCIATION'S 79TH SCIENTIFIC SESSIONS (ADA) “IFNα Kinoid: [...]
Néovacs présente les résultats précliniques de l'IFNalpha Kinoïde pour le traitement du diabète de type 1 - 79ème conférence scientifique de l'American Diabetes Association
05/06/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS PRÉSENTE LES R É SULTATS PR É CLINIQUES DE L’IFN α KINO Ϊ DE POUR LE TRAITEMENT DU DIAB È TE DE TYPE 1 LORS DE LA 79 EME CONF É RENCE [...]
DEINOVE & Dow sign a collaboration agreement for the development of a new cosmetic active ingredient
05/06/2019
DEINOVE & Dow sign a collaboration agreement for the development of a new cosmetic active ingredient Dow has selected an extract belonging to the DEINOVE proprietary strains’ bank to launch a new cosmetic active [...]
DEINOVE & Dow signent un accord de collaboration pour le développement d’un nouvel actif cosmétique
05/06/2019
DEINOVE & Dow signent un accord de collaboration pour le développement d’un nouvel actif cosmétique Dow a sélectionné un extrait issu de la collection bactérienne propriétaire de DEINOVE pour mettre sur le marché un [...]
Hua Medicine – Business & Pipeline Update
05/06/2019
Trial Products Exploratory NDA Enabling Description / Indication HMM0301 Dorzagliatin (HMS5552) Phase III ongoing Drug-naïve T2D HMM0302 Dorzagliatin + Metformin Phase III ongoing Metformin tolerant T2D New HMM0303 [...]
Reata Announces Presentations at the 56th Congress of the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA)
05/06/2019
IRVING, Texas, June 04, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that four abstracts highlighting Reata’s progress in developing [...]
Sientra Announces Pricing of Upsized Public Offering of Common Stock
05/06/2019
SANTA BARBARA, Calif., June 04, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced the upsizing and pricing of its previously announced [...]
INmune Bio to present Alzheimer’s Drug Candidate XPro1595 at The TNF Conference
04/06/2019
LA JOLLA, Calif., June 04, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today [...]
Sarepta Therapeutics to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
04/06/2019
CAMBRIDGE, Mass., June 04, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the [...]
Genfit: GENFIT Launches a Phase 2 Trial Evaluating Elafibranor on Hepatic Lipid Composition for NAFL
04/06/2019
GENFIT Launches a Phase 2 Trial Evaluating Elafibranor on Hepatic Lipid Composition for NAFL Study objective to determine the effect of elafibranor, a dual PPAR alpha/delta agonist, on fatty acid saturation Phase 2 [...]
Genfit: GENFIT lance un essai de Phase 2 évaluant l’effet d’elafibranor sur la composition lipidique du foie dans la stéatose hépatique
04/06/2019
GENFIT lance un essai de Phase 2 évaluant l’effet d’elafibranor sur la composition lipidique du foie dans la stéatose hépatique L’étude a pour objectif de déterminer l’effet d’elafibranor, un double agoniste des PPAR [...]
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/06/2019
RESEARCH TRIANGLE PARK, N.C., June 04, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the compensation committee of BioCryst’s board of directors granted four newly-hired [...]
Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention
04/06/2019
GAITHERSBURG, Md., June 04, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced that John J. Trizzino, Senior Vice President, Chief Business Officer and Chief Financial Officer, will join other vaccine [...]

Pages